TWI816128B - Use of extract of angelica dahurica var. formosana - Google Patents
Use of extract of angelica dahurica var. formosana Download PDFInfo
- Publication number
- TWI816128B TWI816128B TW110119860A TW110119860A TWI816128B TW I816128 B TWI816128 B TW I816128B TW 110119860 A TW110119860 A TW 110119860A TW 110119860 A TW110119860 A TW 110119860A TW I816128 B TWI816128 B TW I816128B
- Authority
- TW
- Taiwan
- Prior art keywords
- extract
- duhuo
- formosana
- hair growth
- hair
- Prior art date
Links
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Compounds Of Unknown Constitution (AREA)
Abstract
Description
本發明係關於一種獨活萃取物的用途,尤其是一種獨活萃取物用以製備促進毛髮生長的製劑的用途。The present invention relates to the use of an extract of the plant, particularly the use of the extract of the plant to prepare a preparation for promoting hair growth.
愛美是人的天性,髮量、髮色更是影響一個人外觀的重要關鍵因素。然而,由於飲食或作息不正常、壓力過大等因素,大量掉髮及禿頭現象有年輕化的趨勢。It is human nature to love beauty, and hair volume and hair color are important key factors that affect a person's appearance. However, due to factors such as abnormal diet or work and rest, excessive stress, etc., massive hair loss and baldness tend to occur at a younger age.
毛囊(hair follicle)為位於真皮層(dermal layer)中的器官,毛乳頭(papillae)則以皮脂腺(sebaceous gland)連結毛囊,以為生長中的毛髮提供養分及氧氣,因此若是毛乳頭發生萎縮或受傷,毛髮就會停止生長,並出現脫髮(hair loss)﹝亦稱為脫毛(alopecia)或禿髮(baldness)﹞。The hair follicle is an organ located in the dermal layer. The papillae is connected to the hair follicles with sebaceous glands to provide nutrients and oxygen to the growing hair. Therefore, if the papilla atrophies or is injured, , hair will stop growing and hair loss (also called alopecia or baldness) will occur.
習知用以治療脫髮的藥物包含米諾地爾(minoxidil)及非那斯特萊(finasteride)等,然而,米諾地爾可能會造成眼睛的灼熱(burning)或刺激(irritation)、治療部位的發癢(itching)、發紅(redness)或刺激等副作用,非那斯特萊則可能會導致性功能障礙(sexual dysfunction),有鑑於此,若是能夠進一步找到能夠促進毛髮生長的植物藥物,確實有助於改善脫髮的問題。Drugs commonly used to treat hair loss include minoxidil and finasteride. However, minoxidil may cause burning or irritation of the eyes and the treatment area. Itching, redness or irritation and other side effects, while finasteride may cause sexual dysfunction. In view of this, if we can further find botanical drugs that can promote hair growth, It really helps to improve the problem of hair loss.
為解決上述問題,本發明的目的是提供一種獨活萃取物的用途,係用以製備促進毛髮生長的製劑者。In order to solve the above problems, the object of the present invention is to provide a use of the Indica odorifera extract, which is used to prepare preparations for promoting hair growth.
本發明的獨活萃取物的用途,係用以製備促進毛髮生長的製劑,該獨活萃取物係施予於一所需個體的皮膚上,以促進該所需個體之毛髮生長;其中,該獨活萃取物可以為於55~65℃之溫度下,以水萃取一獨活樣品所獲得。The use of the Duhuo extract of the present invention is to prepare a preparation for promoting hair growth. The Duhuo extract is applied to the skin of a desired individual to promote hair growth of the desired individual; wherein, the The Tuho extract can be obtained by extracting a Tuho sample with water at a temperature of 55 to 65°C.
據此,本發明的獨活萃取物的用途,係藉由萃取自該獨活樣品的活性成分,可以活化毛囊真皮乳頭細胞,使毛囊真皮乳頭細胞具有良好的酵素活性(如,鹼性磷酸酶的活性),進而可以促進毛髮的生長,因而可以應用於製備促進毛髮生長的製劑,為本發明之功效。Accordingly, the use of the Indica extract of the present invention is to activate hair follicle dermal papilla cells through the active ingredients extracted from the Indigo sample, so that the hair follicle dermal papilla cells have good enzyme activity (such as alkaline phosphatase activity), thereby promoting hair growth, and therefore can be used to prepare preparations for promoting hair growth, which is the effect of the present invention.
本發明的獨活萃取物的用途,其中,該獨活萃取物係能夠以塗抹、噴灑等方式施予該所需個體。如此,使用者可以輕鬆地將該獨活萃取物施予該所需個體的皮膚上。The use of the Kuo Kuo extract of the present invention, wherein the Kuo Kuo extract can be administered to the desired individual by smearing, spraying, etc. In this way, the user can easily apply the single-life extract to the skin of the desired individual.
本發明的獨活萃取物的用途,其中,該獨活萃取物係能夠以1.5~3.0 mg/cm 2的劑量施予該所需個體。如此,使該獨活萃取物可以有效地促進毛髮生長。 The use of the Kusanagi extract of the present invention, wherein the Kusanagi extract can be administered to the desired individual at a dose of 1.5 to 3.0 mg/cm 2 . In this way, the Duhuo extract can effectively promote hair growth.
為讓本發明之上述及其他目的、特徵及優點能更明顯易懂,下文特舉本發明之較佳實施例,並配合所附圖式,作詳細說明如下:In order to make the above and other objects, features and advantages of the present invention more obvious and understandable, the following describes the preferred embodiments of the present invention in detail with reference to the accompanying drawings:
本發明所述之「製劑」係指將一活性成分加工調製,製成特定劑型,且包含一定劑量之藥品及化妝品,本發明之「促進毛髮生長的製劑」則可以活化毛囊真皮乳頭細胞(dermal papilla cell,DPC cell),使毛囊真皮乳頭細胞具有良好的活性,進而可以促進毛髮的生長,此為本發明所屬技術領域中具有通常知識者可以理解,於此不再贅述。The "preparation" mentioned in the present invention refers to an active ingredient processed and prepared into a specific dosage form, and contains a certain dose of drugs and cosmetics. The "preparation for promoting hair growth" of the present invention can activate hair follicle dermal papilla cells (dermal papilla cell (DPC cell), which enables the hair follicle dermal papilla cells to have good activity, thereby promoting hair growth. This can be understood by those with ordinary knowledge in the technical field to which the present invention belongs, and will not be described again here.
本發明所述之「獨活樣品」,係指傘形科(Apiaceae)植物重齒毛當歸( Angelica dahuricavar. formosana)的根部樣品,已知具有抗發炎、鎮痛等作用,亦具有降血壓的活性。 The "Independent Living Sample" mentioned in the present invention refers to the root sample of Angelica dahurica var. formosana , a plant of the Apiaceae family, which is known to have anti-inflammatory, analgesic and other effects, and also has the ability to lower blood pressure. active.
本發明之獨活萃取物,係可以使毛囊真皮乳頭細胞具有良好的活性,為生長中的毛髮提供足夠的養分及氧氣,防止脫髮的發生,因而可以應用於製備促進毛髮生長的製劑,該獨活萃取物可以與至少一醫藥學上可接受之載體共同組成該製劑,或是於該製劑中額外添加他種促進毛髮生長之活性成分,以共同投予一所需個體(例如能夠以1.5~3.0 mg/cm 2的劑量施予於該所需個體的皮膚上),該載體係為一賦型劑或一添加劑,較佳係可以共同形成液狀、乳液狀、乳霜狀或膠狀等各種型態之製劑,進而能夠便於該所需個體的使用。 The Duhuo extract of the present invention can make hair follicle dermal papilla cells have good activity, provide sufficient nutrients and oxygen for growing hair, and prevent hair loss. Therefore, it can be used to prepare preparations that promote hair growth. The live extract can be combined with at least one pharmaceutically acceptable carrier to form the preparation, or other active ingredients that promote hair growth can be additionally added to the preparation to co-administer it to a desired individual (for example, it can be administered at 1.5 to A dose of 3.0 mg/cm 2 is applied to the skin of the desired individual), the carrier system is an excipient or an additive, preferably it can jointly form a liquid, emulsion, cream or gel, etc. Various types of preparations can be conveniently used by the desired individuals.
該獨活萃取物較佳可以藉由一包含以下步驟之方法所製得:提供該獨活樣品;以水作為一萃取溶劑萃取該獨活樣品;及將一獨活粗萃液進行濃縮,以獲得該獨活萃取物。The Tuho extract can preferably be prepared by a method comprising the following steps: providing the Tuho sample; extracting the Tuho sample using water as an extraction solvent; and concentrating a crude Tuho extract to Obtain this extract.
詳而言之,該獨活樣品可以為重齒毛當歸的根部樣品,工者較佳可以預先將該獨活樣品進行乾燥,得到一獨活乾燥物,其含水量約低於5%;此外,該獨活樣品亦可以預先碎成粒徑約為2~3 mm的粉粒,以增加該獨活樣品與該萃取溶劑之接觸表面積,藉此提升後續萃取之萃取效率。To be specific, the Duhuo sample can be a root sample of Angelica officinale. Workers can preferably dry the Duhuo sample in advance to obtain a dried Duhuo product with a moisture content of less than 5%; in addition, The Duhuo sample can also be pre-crushed into powder particles with a particle size of about 2 to 3 mm to increase the contact surface area between the Duhuo sample and the extraction solvent, thereby improving the extraction efficiency of subsequent extractions.
舉例而言,每200克的獨活樣品係能夠混合500毫升的該萃取溶劑,並於55~65℃之溫度下進行萃取2小時,使該獨活樣品所富含之活性成分可以完整溶出於該萃取溶劑,此為本發明所屬技術領域中具有通常知識者所廣泛應用,在此不加以贅述。For example, 500 ml of the extraction solvent can be mixed with every 200 grams of Duhuo sample and extracted at a temperature of 55-65°C for 2 hours, so that the active ingredients rich in the Duhuo sample can be completely dissolved into the The extraction solvent is widely used by those with ordinary knowledge in the technical field to which the present invention belongs, and will not be described in detail here.
前述之獨活粗萃液可以經過減壓濃縮及冷凍乾燥,以獲得該獨活萃取物,藉由此一程序,係可以使該獨活萃取物之活性成分更加濃縮,是以僅需使用少量之該獨活萃取物即可以發揮最佳療效。The aforementioned crude extract of Tuho can be concentrated under reduced pressure and freeze-dried to obtain the Tuho extract. Through this procedure, the active ingredients of the Tuho extract can be more concentrated, so only a small amount is needed. This alone extract can exert the best therapeutic effect.
為證實本發明之獨活萃取物確實可以使毛囊真皮乳頭細胞具有良好的活性,遂依第1表所示,於60℃之溫度下,以水萃取該獨活樣品,以獲得第A3組的獨活萃取物(總產量為8.5克);於100℃之溫度下,以水萃取獲得第A4組的獨活萃取物(總產量為13.6克);於60℃之溫度下,以濃度為75%的乙醇水溶液萃取獲得第A5組的獨活萃取物(總產量為6.5克);及於60℃之溫度下,以濃度為95%的乙醇水溶液萃取獲得第A6組的獨活萃取物(總產量為5.6克)。In order to confirm that the Duhuo extract of the present invention can indeed bring good activity to hair follicle dermal papilla cells, as shown in Table 1, the Duhuo sample was extracted with water at a temperature of 60°C to obtain Group A3. Extract of Kuo Kuo extract (total yield: 8.5 grams); Extract with water at a temperature of 100°C to obtain the Kuko Kuyo extract of Group A4 (total yield: 13.6 grams); Extract at a temperature of 60°C with a concentration of 75 % of the ethanol aqueous solution to obtain the extract of Group A5 (total yield: 6.5 grams); and at a temperature of 60°C, extract the aqueous ethanol solution of 95% to obtain the extract of Group A6 (total yield: 6.5 grams). Yield is 5.6 g).
第1表、各組獨活萃取物的萃取溫度及所使用的萃取溶劑
接著,將第A3~A6組獨活萃取物分別加入培養有毛囊真皮乳頭細胞的96孔盤中,各孔中的細胞數量為1×10 4個,且獨活萃取物的濃度為3 mg/mL。在37℃之溫度、5%之二氧化碳濃度的培養箱中培養24小時之後,去除各孔中的培養液,並以清洗溶液(Hepes BSS solution)清洗,再加入100 μL的培養液及20 μL的MTS溶液(MTS assay solution),反應2.5小時之後,以酵素免疫分析測讀儀(ELISA reader)偵測波長為490 nm下的吸光值,進而換算各組毛囊真皮乳頭細胞的細胞生長量。 Then, the Duhuo extracts from groups A3 to A6 were added to a 96-well plate cultured with hair follicle dermal papilla cells. The number of cells in each well was 1×10 4 and the concentration of the Duhuo extract was 3 mg/ mL. After culturing for 24 hours in an incubator at 37°C and 5% carbon dioxide, remove the culture medium from each well and wash with Hepes BSS solution, then add 100 μL of culture medium and 20 μL of MTS assay solution, after reacting for 2.5 hours, use an enzyme immunoassay reader (ELISA reader) to detect the absorbance value at a wavelength of 490 nm, and then convert the cell growth amount of hair follicle dermal papilla cells in each group.
請參照第1圖所示,加入第A3組獨活萃取物的毛囊真皮乳頭細胞的細胞生長量最多,且效果遠優於第A4~A6組獨活萃取物(*: P<0.05;***: P<0.001)。再且,第A3組獨活萃取物的細胞生長促進效果與正控制組之A1、A2組(濃度為10或5 μg/mL的腺苷)效果相近,且與僅加入培養液的第A7組亦有明顯差異。 Please refer to Figure 1. The hair follicle dermal papilla cells that were added to the A3 group of Toko extracts had the largest cell growth, and the effect was much better than that of the A4 to A6 groups of Toko extracts (*: P <0.05; ** *: P <0.001). Furthermore, the cell growth-promoting effect of the Duhuo extract in Group A3 was similar to that of the positive control groups A1 and A2 (adenosine at a concentration of 10 or 5 μg/mL), and was similar to that of Group A7 that only added culture medium. There are also obvious differences.
接著,將前述各組細胞裂解之後,於25℃之溫度、13,000 rpm之轉速下離心3分鐘,取其上清液加入96孔盤中,再加入dNPP溶液、鹼性磷酸酶(alkaline phosphatase,ALP)溶液,於室溫下反應60分鐘後,再加入終止溶液(stop solution),以酵素免疫分析測讀儀偵測波長為405 nm下的吸光值,進而換算各組毛囊真皮乳頭細胞的鹼性磷酸酶的酵素活性。Next, after lysing the cells in each of the aforementioned groups, centrifuge at 25°C and 13,000 rpm for 3 minutes, add the supernatant to a 96-well plate, and then add dNPP solution and alkaline phosphatase (ALP). ) solution, react at room temperature for 60 minutes, then add the stop solution, use an enzyme immunoassay reader to detect the absorbance value at a wavelength of 405 nm, and then convert the alkalinity of the hair follicle dermal papilla cells in each group Phosphatase enzyme activity.
請參照第2圖所示,加入第A3組獨活萃取物的毛囊真皮乳頭戲胞的鹼性磷酸酶的酵素活性最佳,且其效果亦優於第A4~A6組獨活萃取物,亦優於濃度為5 μg/mL的腺苷(第A2組)(*: P<0.05;**: P<0.01;***: P<0.001)。 Please refer to Figure 2. The enzyme activity of alkaline phosphatase in the dermal papilla cells of hair follicles added to the A3 group of univitae extracts is the best, and its effect is also better than that of the A4 to A6 groups of univitae extracts. It is also Better than adenosine at a concentration of 5 μg/mL (Group A2) (*: P <0.05; **: P <0.01; ***: P <0.001).
綜上所述,本發明的獨活萃取物的用途,係藉由萃取自該獨活樣品的活性成分,可以活化毛囊真皮乳頭細胞,使毛囊真皮乳頭細胞具有良好的酵素活性(如,鹼性磷酸酶的活性),進而可以促進毛髮的生長,因而可以應用於製備促進毛髮生長的製劑,為本發明之功效。To sum up, the purpose of the Duhuo extract of the present invention is to activate the hair follicle dermal papilla cells through the active ingredients extracted from the Duhuo sample, so that the hair follicle dermal papilla cells have good enzyme activity (such as alkaline Phosphatase activity), thereby promoting hair growth, and therefore can be used to prepare preparations for promoting hair growth, which is the effect of the present invention.
雖然本發明已利用上述較佳實施例揭示,然其並非用以限定本發明,任何熟習此技藝者在不脫離本發明之精神和範圍之內,相對上述實施例進行各種更動與修改仍屬本發明所保護之技術範疇,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。Although the present invention has been disclosed using the above-mentioned preferred embodiments, they are not intended to limit the invention. Anyone skilled in the art can make various changes and modifications to the above-described embodiments without departing from the spirit and scope of the invention. The technical scope protected by the invention, therefore, the scope of protection of the invention shall be determined by the appended patent application scope.
無without
[第1圖] 各組獨活萃取物對細胞生長之影響的柱狀圖。 [第2圖] 各組獨活萃取物對鹼性磷酸酶的酵素活性之影響的柱狀圖。 [Picture 1] A bar graph showing the effects of each group of Duhuo extracts on cell growth. [Picture 2] A bar graph showing the effect of each group of Duhuo extracts on the enzyme activity of alkaline phosphatase.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW110119860A TWI816128B (en) | 2021-06-01 | 2021-06-01 | Use of extract of angelica dahurica var. formosana |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW110119860A TWI816128B (en) | 2021-06-01 | 2021-06-01 | Use of extract of angelica dahurica var. formosana |
Publications (2)
Publication Number | Publication Date |
---|---|
TW202247849A TW202247849A (en) | 2022-12-16 |
TWI816128B true TWI816128B (en) | 2023-09-21 |
Family
ID=85793432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW110119860A TWI816128B (en) | 2021-06-01 | 2021-06-01 | Use of extract of angelica dahurica var. formosana |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI816128B (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2348025A1 (en) * | 2008-10-21 | 2011-07-27 | Kao Corporation | Nfat signal inhibitor and hair-growing agent |
-
2021
- 2021-06-01 TW TW110119860A patent/TWI816128B/en active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2348025A1 (en) * | 2008-10-21 | 2011-07-27 | Kao Corporation | Nfat signal inhibitor and hair-growing agent |
Non-Patent Citations (1)
Title |
---|
期刊 Mao Deng,et al. "Imperatorin: A review of its pharmacology, toxicity and pharmacokinetics", European Journal of Pharmacology, 879, 173124 1~11, ,Available online 24 April 2020 * |
Also Published As
Publication number | Publication date |
---|---|
TW202247849A (en) | 2022-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101878069B1 (en) | Composition comprising herbal mixture extracts and hinoki oil for preventing or treating acne and atopic dermatitis | |
KR101132246B1 (en) | The hair growth solution mainly comprised of ginsenoside rg3 and rh2, and the hair treatment composition | |
CA2517371C (en) | Method for the production of flavonoid-containing compositions and their use | |
CN112870333A (en) | Composition and preparation for improving alopecia and promoting hair growth of human, and preparation method and application thereof | |
JPH0717845A (en) | Skin external preparation | |
WO2017036241A1 (en) | Acne-removing traditional chinese medicine composition and preparation method thereof | |
KR101654308B1 (en) | Composition for improving hair having effect of depilation prevention and good hair | |
KR101547758B1 (en) | Composition for preventing hair loss and promoting hair growth | |
KR102101949B1 (en) | A skin-care agent or cosmetics containig Antrodia camphorata fruit body extract or Antrodia camphorata mycelium extract | |
CN108815111A (en) | A kind of traditional Chinese medicine freckle-removing whitening remediation composition and preparation method thereof | |
KR101286266B1 (en) | Composition for hair loss prevention and/or hair growth promotion comprising fermented pruni cortex | |
CN113181097A (en) | Acne-removing spot-fading plant compound hydrolat and preparation method and application thereof | |
TWI816128B (en) | Use of extract of angelica dahurica var. formosana | |
KR101252550B1 (en) | Cosmetic composition for protecting sebum secretion on the skin | |
CN108938543A (en) | A kind of lip treatments and preparation method thereof preventing and treating cheilitis | |
KR100610951B1 (en) | Composition for Skin-antiacne | |
TWI775462B (en) | Use of extract of barley malt | |
KR101724870B1 (en) | Hair growth promoting composition having curative inflammation and Wnt /? - catenin signaling activity | |
KR102262791B1 (en) | A composition for improving skin function comprising fermented herb extracts | |
JP4197194B2 (en) | Oral administration agent for intercellular adhesion suppression | |
JP2002526395A (en) | Use of Bold extract in cosmetic or dermatological products | |
US20020041908A1 (en) | Iridacea extracts for stimulating the immune system | |
CN114948932B (en) | Use of a composition comprising mulberenone for the preparation of a product for the prevention and treatment of hair loss by acting on the hair follicle tissue | |
KR101273027B1 (en) | Composition for inhibiting sebum secretion and anti-obesity comprising kaempferol | |
KR20140111142A (en) | Angelica keiskei extract and method of manufacturing the same |